US Stock MarketDetailed Quotes

SABS SAB Biotherapeutics

Watchlist
  • 4.4000
  • +0.0400+0.92%
Close Apr 24 16:00 ET
40.59MMarket Cap-575P/E (TTM)

About SAB Biotherapeutics Company

SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company. It is engaged in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The firm produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases. SAB Biotherapeutics was founded by Eddie J. Sullivan and Christine E. Hamilton in July 2014 and is headquartered in Sioux Falls, SD.

Company Profile

SymbolSABS
Company NameSAB Biotherapeutics
Listing DateFeb 9, 2021
Founded2014
CEOMr. Samuel J. Reich
MarketNASDAQ
Employees57
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2100 East 54th Street North
CitySioux Falls
ProvinceSouth Dakota
CountryUnited States of America
Zip Code57104
Phone1-605-679-6980
Websitehttp://www.sab.bio

Company Executives

  • Name
  • Position
  • Salary
  • Samuel J. Reich
  • Chief Executive Officer and Director
  • 304.60K
  • Christoph Lawrence Bausch
  • Chief Operating Officer
  • --
  • Dr. Alexandra Kropotova, M.D.
  • Chief Medical Officer and Executive Vice President
  • 865.14K
  • Michael King
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Eddie J. Sullivan, PhD
  • Director and President
  • 475.34K
  • David Link, M.B.A.
  • Vice Chairman of the Board
  • 25.00K
  • Jeffrey G. Spragens
  • Independent Director
  • 23.41K
  • Erick J. Lucera, C.F.A.
  • Independent Director
  • --
  • Andrew D. Moin
  • Independent Director
  • --
  • Christine Hamilton
  • Independent Director
  • 25.00K
  • Helen Katherine Ellias
  • Independent Director
  • --
  • Dr. William Polvino, M.D.
  • Independent Director
  • 25.00K
  • Admiral Scott Giberson, (Ret.)
  • Independent Director
  • 19.93K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg